UnitedHealth Group Inc (UNH) Shares Sold by Meag Munich Ergo Kapitalanlagegesellschaft MBH

Meag Munich Ergo Kapitalanlagegesellschaft MBH trimmed its stake in UnitedHealth Group Inc (NYSE:UNH) by 55.8% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 102,080 shares of the healthcare conglomerate’s stock after selling 128,653 shares during the quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH’s holdings in UnitedHealth Group were worth $20,080,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. Regal Wealth Group Inc. lifted its stake in UnitedHealth Group by 0.4% in the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after buying an additional 3 shares during the last quarter. Jackson Grant Investment Advisers Inc. increased its holdings in shares of UnitedHealth Group by 0.4% during the second quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after purchasing an additional 4 shares during the period. RB Capital Management LLC increased its holdings in shares of UnitedHealth Group by 0.4% during the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after purchasing an additional 7 shares during the period. RNC Capital Management LLC increased its holdings in shares of UnitedHealth Group by 0.7% during the second quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after purchasing an additional 13 shares during the period. Finally, Highland Private Wealth Management increased its holdings in shares of UnitedHealth Group by 0.4% during the second quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock valued at $593,000 after purchasing an additional 13 shares during the period. Institutional investors own 86.01% of the company’s stock.

UnitedHealth Group Inc (NYSE UNH) opened at $225.88 on Wednesday. The stock has a market capitalization of $218,390.00, a PE ratio of 25.67, a P/E/G ratio of 1.57 and a beta of 0.66. UnitedHealth Group Inc has a fifty-two week low of $156.09 and a fifty-two week high of $231.77. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group’s revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company earned $2.17 earnings per share. analysts anticipate that UnitedHealth Group Inc will post 9.99 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date was Thursday, November 30th. UnitedHealth Group’s payout ratio is currently 34.09%.

In related news, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction on Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the transaction, the chief executive officer now owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,630 shares of company stock worth $7,669,416. 0.89% of the stock is owned by corporate insiders.

A number of brokerages have recently commented on UNH. Goldman Sachs Group began coverage on UnitedHealth Group in a report on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price target on the stock. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Cantor Fitzgerald reissued a “buy” rating and set a $235.00 price target on shares of UnitedHealth Group in a report on Monday, December 25th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Finally, Raymond James Financial reissued a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 6th. Three equities research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $226.74.

COPYRIGHT VIOLATION NOTICE: This piece was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be read at https://www.com-unik.info/2018/01/10/unitedhealth-group-inc-unh-shares-sold-by-meag-munich-ergo-kapitalanlagegesellschaft-mbh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

What are top analysts saying about UnitedHealth Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit